069620.KO Daewoong Pharma

Healthcare Pharmaceuticals Korea Stock Exchange
106,700 KRW
Close of Nov 5, 2026
98,400 198,713
Market cap
KRW 1.23T
P/E
6.1x
P/B
1.11x
ROE
11.1%
Dividend yield
0.66%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 069620.KO undervalued?

Graham number
Price106,700
Graham value194,946
Discount45.3%

069620.KO trades 45.3% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Daewoong Pharma fundamental analysis

No fundamental analysis for Daewoong Pharma yet.

Daewoong Pharma stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Daewoong Pharma

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 Ig…

Full company profile